Iris BioTechnologies, Inc. announced that it has received $0.58 million in funding

Iris Biotechnologies Inc. (Iris) is a United States-based life sciences company, which focuses on precision medicine. The Company has developed a technology platform to determine an approach to cancer diagnosis and treatment. The Company's efforts are principally devoted to developing solutions for the detection and monitoring of monogenic and complex genomic diseases. The Company is in preparation for the launch of multiple products and services-based upon its Nano-biochip and BioWindows Medical Informatics System. Its Nano-Biochip product pipeline includes CancerChip, PrenatalChip, NeuroChip (Alzheimer's and Parkinson diseases), MetabolicChip (Diabetes), CardioChip, BloodChip and Chips for veterinary, agricultural (biofuel development), environmental, and other applications. Its BioWindows artificial intelligence system provides big data and analysis for clinical applications, drug development and stem cell research.